Monday, October 24, 2016 5:39:05 PM
While IPCI might have mild success with there NDA products, such as Rexista and Pregabatin, it is very difficult to come up with a blockbuster drug. So I would be skeptical that IPCI can duplicate Biovail's success.
A Wellbutrin XL type of deal would be if IPCI and Pfizer partnered for Lyrica XR, using IPCI's version of the drug. Wellbutrin XL was the extended-release version when Wellbutrin immediate-release was coming off-patent. In a few years, immediate-release Lyrica is coming off-patent. That is why Pfizer is developing extended-release Lyrica, so I doubt Pfizer would want to partner with IPCI.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM